29.10
-0.53(-1.79%)
Currency In USD
| Previous Close | 29.63 |
| Open | 29.59 |
| Day High | 29.91 |
| Day Low | 28.94 |
| 52-Week High | 42.29 |
| 52-Week Low | 27.28 |
| Volume | 270,962 |
| Average Volume | 411,291 |
| Market Cap | 916.23M |
| PE | 15.65 |
| EPS | 1.86 |
| Moving Average 50 Days | 30.65 |
| Moving Average 200 Days | 33.25 |
| Change | -0.53 |
If you invested $1000 in Collegium Pharmaceutical, Inc. (COLL) since IPO date, it would be worth $2,367.78 as of March 14, 2025 at a share price of $29.1. Whereas If you bought $1000 worth of Collegium Pharmaceutical, Inc. (COLL) shares 5 years ago, it would be worth $1,888.38 as of March 14, 2025 at a share price of $29.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care
GlobeNewswire Inc.
Mar 10, 2025 10:57 PM GMT
STOUGHTON, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have two poster presentations highlighting real-world data from its differentiated neuropsychiatry product, Jornay PM, (methy
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
GlobeNewswire Inc.
Feb 13, 2025 1:00 PM GMT
STOUGHTON, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report fourth quarter and full-year 2024 financial results after the market closes on Thursday, February 27, 2025. Follow
Collegium Appoints Nancy S. Lurker to its Board of Directors
GlobeNewswire Inc.
Feb 05, 2025 1:00 PM GMT
STOUGHTON, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the appointment of Nancy S. Lurker to its Board of Directors, effective February 4, 2025. “Collegium is pleased to welcome Nancy to ou